customer service software
0

ANGLE plc (AGL) - Product Pipeline Analysis, 2018 Update

  • Published Date: 27 Dec 2018
  • Number of Pages: 37
  • Category: Company Profile
  • Country: United Kingdom
Summary

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individuals condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLEs Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The companys cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patients cancer for personalized cancer care. The companys harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ANGLE plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy
:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
ANGLE plc Company Overview 5
ANGLE plc Company Snapshot 5
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc Pipeline Analysis Overview 8
ANGLE plc - Key Facts 8
ANGLE plc - Major Products and Services 9
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Pipeline Products Overview 14
Parsortix GEN2 14
Parsortix GEN2 Product Overview 14
Parsortix System 15
Parsortix System Product Overview 15
Parsortix-Based Test - Breast Cancer 16
Parsortix-Based Test - Breast Cancer Product Overview 16
Parsortix-Based Test - Colorectal Cancer 17
Parsortix-Based Test - Colorectal Cancer Product Overview 17
Parsortix-Based Test - Head & Neck Cancer 18
Parsortix-Based Test - Head & Neck Cancer Product Overview 18
Parsortix-Based Test - Lung Cancer 19
Parsortix-Based Test - Lung Cancer Product Overview 19
Parsortix-Based Test - Ovarian Cancer Triage 20
Parsortix-Based Test - Ovarian Cancer Triage Product Overview 20
Parsortix-Based Test - Ovarian Cancer Triage Clinical Trial 21
Parsortix-Based Test - Pancreatic Cancer 22
Parsortix-Based Test - Pancreatic Cancer Product Overview 22
Parsortix-Based Test - Prostate Cancer 23
Parsortix-Based Test - Prostate Cancer Product Overview 23
ANGLE plc - Key Competitors 24
ANGLE plc - Key Employees 25
ANGLE plc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
ANGLE plc, Recent Developments 27
Jun 04, 2018: ANGLE: Encouraging Progress in ANG-002 FDA Clinical Study 27
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
May 03, 2018: Angle and Qiagen Present Poster at Leading Cancer Conference Demonstrating Utility of Angles Parsortix System in Conjunction With Qiagens Adnatest Assay 28
Apr 19, 2018: Angles Parsortix System Showcased In Multiple Presentations At Leading Cancer Conference AACR 2018 28
Apr 19, 2018: Breakthrough Research Demonstrates Parsortix Workflow For Culturing Circulating Tumor Cells For In-Vitro Drug Testing 29
Apr 05, 2018: First Patient Enrolled In Clinical Study To Support FDA Clearance Of The Parsortix System 30
Mar 26, 2018: AngleS Ovarian Cancer Risk Assessment Achieves The Highest Sensitivity And Specificity For Predicting Cancer 30
Feb 06, 2018: ANGLE: Research Grant From Abbott 31
Jan 31, 2018: ANGLE: Interim Results for the six months ended 31 October 2017 32
Jan 16, 2018: ANGLE: Webinar: Using The Parsortixtm System To Identify Drugs That May Arrest Cancer Metastasis 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List Of Tables


ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Indication 7
ANGLE plc Ongoing Clinical Trials by Trial Status 7
ANGLE plc, Key Facts 8
ANGLE plc, Major Products and Services 9
ANGLE plc Number of Pipeline Products by Development Stage 10
ANGLE plc Pipeline Products Summary by Development Stage 11
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Ongoing Clinical Trials Summary 13
Parsortix GEN2 - Product Status 14
Parsortix GEN2 - Product Description 14
Parsortix System - Product Status 15
Parsortix System - Product Description 15
Parsortix-Based Test - Breast Cancer - Product Status 16
Parsortix-Based Test - Breast Cancer - Product Description 16
Parsortix-Based Test - Colorectal Cancer - Product Status 17
Parsortix-Based Test - Colorectal Cancer - Product Description 17
Parsortix-Based Test - Head & Neck Cancer - Product Status 18
Parsortix-Based Test - Head & Neck Cancer - Product Description 18
Parsortix-Based Test - Lung Cancer - Product Status 19
Parsortix-Based Test - Lung Cancer - Product Description 19
Parsortix-Based Test - Ovarian Cancer Triage - Product Status 20
Parsortix-Based Test - Ovarian Cancer Triage - Product Description 20
Parsortix-Based Test - Ovarian Cancer Triage - Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting with a Pelvic Mass: ANG-003 EMBER Study 21
Parsortix-Based Test - Pancreatic Cancer - Product Status 22
Parsortix-Based Test - Pancreatic Cancer - Product Description 22
Parsortix-Based Test - Prostate Cancer - Product Status 23
Parsortix-Based Test - Prostate Cancer - Product Description 23
ANGLE Plc, Key Employees 25
ANGLE Plc, Other Locations 26
Glossary 36

List Of Figures


ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12

SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to

View Report

Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products

View Report

GenomicTree Inc (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports